Cancer Center Cessation Initiative (C3I)
In 2017, NCI launched the Cancer Center Cessation Initiative, or C3I, as part of the NCI Cancer Moonshot℠ program. The long-term goal of this Initiative is to help cancer centers build and implement sustainable tobacco cessation treatment programs to routinely address tobacco cessation with cancer patients.
Which cancer centers received funding through the C3I?
(in alphabetical order)
- Dan L. Duncan Cancer Center, Baylor College of Medicine
- Case Comprehensive Cancer Center, Case Western Reserve University
- Duke Cancer Center, Duke University Medical Center
- Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
- Melvin and Bren Simon Cancer Center, Indiana University
- Hollings Cancer Center, Medical University of South Carolina
- Laura and Isaac Perlmutter Cancer Center, New York University Medical Center
- University of California Davis Cancer Center, University of California – Davis
- University of Chicago Comprehensive Cancer Center, University of Chicago
- University of Colorado Cancer Center, University of Colorado
- Holden Comprehensive Cancer Center, University of Iowa
- University of Kansas Cancer Center, University of Kansas
- Markey Cancer Center, University of Kentucky
- Masonic Cancer Center, University of Minnesota
- University of New Mexico Cancer Research & Treatment Center, University of New Mexico
- UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
- Abramson Cancer Center, University of Pennsylvania
- Huntsman Cancer Institute, University of Utah
- University of Virginia Cancer Center, University of Virginia
- Vanderbilt-Ingram Cancer Center, Vanderbilt University
- Siteman Cancer Center, Washington University School of Medicine
- Yale Cancer Center, Yale University
How will the funded sites enhance the delivery of tobacco cessation treatment at their cancer center?
- Refining electronic medical records and clinical workflows to ensure the systematic identification and documentation of smokers and the routine delivery of evidence-based tobacco cessation treatment services
- Overcoming patient, clinician, clinic, and health system barriers to providing tobacco cessation treatment services
- Achieving institutional buy-in that treating tobacco use is a component of organizational “Standard of Care”
- Creating mechanisms to sustain tobacco cessation treatment services so that they continue beyond the funding period of the initiative
What will the C3I Coordinating Center do?
The C3I Coordinating Center will be based at the University of Wisconsin Carbone Cancer Center. The Coordinating Center will support the funded sites by:
- Ensuring that science-based smoking cessation treatment services are integrated into the clinical care of funded cancer centers
- Providing technical assistance in the areas of electronic health record (EHR) integration, clinical workflow change management, and addressing health disparities as they relate to the delivery of smoking cessation treatment services
- Serving as the hub of knowledge integration, including the sharing of best practices across funded Centers and for the cancer clinical community more broadly.
Who can I contact for more information?
What funding opportunities exist for tobacco control research?
What smoking cessation resources are available?
- Tobacco Use and Cessation in Cancer Screening, Diagnosis, Treatment, and Survivorship
- Chapter 6, Cancer, The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General. (January 2014)
- Harms of Smoking and Benefits of Smoking Cessation
- PHS Clinical Practice Guideline - Treating Tobacco Use and Dependence, 2008 Update